In the EVOKE Study, the Clinicians observed…
Reduce Clinical Burden And Improve Practice Efficiency
The EVOKE Study demonstrated a reduction in follow-up office visits due to device reprogramming needs
explants due to loss of efficacy at 36 months1
Reprogramming visits per patient per year1 (beyond 12 months)
Gain Confidence And Peace Of Mind
Deliver consistent neural activation for consistent pain relief
EVOKE Study patients with SmartLoop® technology received therapeutic stimulation 94% of the time compared to open-loop patients receiving therapeutic stimulation 46% of the time.1
Achieve high patient satisfaction
Demonstrated superior outcomes can increase patient awareness
of patients were satisfied with therapy1
Impact of the Evoke System on My Practice
Objective Measurement of Neural Activation
Measuring the activity of the spinal cord and reacting to the measured activity to maintain neural activation that is therapeutic…that’s not been done before.
Jason Pope
MD
Objective Measurement of Neural Activation
The Evoke System gives us for the first time, insights into what the individual actually needs and how that need can be monitored and adjusted to provide the therapy beneficial to them.
Lawrence Poree
MD
Impact on My Practice
We can bring durability, efficacy and objective data to patients to show them the device is working for them
Sean Li
MD
Objective Measurement of Neural Activation
Because we are able to sense and record neural impulses, I don’t hear my patients say my stimulator is not working
Erika Petersen
MD
Impact on My Practice
They weren’t coming in complaining, they weren’t coming in saying my system’s not working, they weren’t coming in saying I need to be reprogrammed…this frees you up to see new patients, it frees you up to see procedures, it frees up your APP to help other patients.
Corey Hunter
MD
Impact of the Evoke System on Patients
We will change the lives of many patients with the type of outcomes measures that were not available in the past
Timothy Deer
MD
